Improved glycemic control can reduce A1c, medical costs and complications… According to a new study, early introduction of insulin could save money, help more patients reach A1c goals and decrease diabetes-related complications and mortality. Currently, insulin therapy for persons with type 2 diabetes is traditionally added to an anti-hyperglycemic regimen …
Read More »Diabetes In Control
Growing Healthier Fat
A new study has identified the mechanisms that turn white fat into healthier brown fat…
Read More »Children with Type 1 Diabetes are Showing Declines in IQ
Evidence suggests that the timing of diabetes onset and exposure to serious hypoglycemia may be factors in the cognitive decline of type 1 diabetics… The new study is the first of its kind to follow intelligence quotient (IQ) in type 1 diabetes patients from diagnosis in childhood into young adulthood …
Read More »FDA Approves Weight-management Drug Saxenda
The U.S. Food and Drug Administration has approved Saxenda as a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity….
Read More »The Importance of Having Standards So Diabetes Devices Can Communicate
Interoperability protocols unveiled for diabetes technologies… The communication protocols define how diabetes devices such as insulin pumps, blood glucose meters, and continuous glucose monitors talk with each other and with other devices such as smart phones and computers. They were developed jointly by JDRF and the Center for Global eHealth …
Read More »FDA Approves Liraglutide (Saxenda) for Weight Loss
FDA Approves Liraglutide (Saxenda) for Weight Loss The U.S. Food and Drug Administration has approved Saxenda (liraglutide [rDNA origin] injection) as a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. See this week’s Item 11. "The approval of Saxenda adds a unique tool …
Read More »Xultophy
The first insulin/incretin mimetic combination launched overseas, Xultophy is a prefilled pen containing a fixed-ratio combination of insulin degludec and liraglutide, licensed in Europe for the treatment of type 2 diabetes in combination with oral hypoglycemics. Xultophy is the first product to combine a basal insulin and an incretin mimetic …
Read More »Daily BG Testing and Medication Log Sheet
Daily BG Testing and Medication Log Sheet What every doc needs to have in his files: a glucose log to start your patients on. When getting your patients on the way to controlling blood sugars, it is important to provide them with a log that you prepare for them, allowing …
Read More »Letter from the Editor, #761
This is the time of year when our patients start to think about their New Year’s resolutions and taking care of their diabetes is one of the things they often decide on. Unfortunately, this is usually used as an excuse to gorge themselves for the rest of the year because …
Read More »Editor’s Note, DCMS #220
Here is a word that’s associated with diabetes that you might not know — microangiopathy. This problem affects between 10-15% of all diabetes patients and is often overlooked, even though it is very simple to diagnose. If you want to know what this condition is and how to diagnose it, then check …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.